+ Watch XON
on My Watchlist
attractive now at this price
One name: Randal J. Kirk
Back down to where insiders bought ($13-15)
insider buying + good stock
Bio what ever is the new tech! Go nerds
There will come a day when we suddenly need lots of stem cells. That day is tomorrow. (or maybe the day after).
Intrexon has innovative gene technology that is winning joint ventures in drugs,food, and agriculture. They just signed up a biggie, Johnson and Johnson.
Synthetic Fish. Probably the end of the world, but I want to see what happens to the stock. Just watching, not investing.
i dont know about biotech but i do know that the world need more food to sustain and need more ways to battle diseases and the alternative is biotech
I feel this is a good play on the unavoidable issue of rapid population growth. There were 3 Billion people on earth in 1850, 4 Billion in 1960, 5 Billion in 1980, 6 Billion in 2000, and 7 billion roughly in 2014. Its no question earth's natural rate of resource renewal will become insufficient at some point to support such a rapidly growing population. Enter synthetic biology. Technology that can cut the growth cycle of a salmon in half for example. Technology to increase Earth's ability to support exponential population growth. Obviously this isn't an issue today and might not even be in 50 years, but the technology developed today will save the human race in the future. I think Intrexon could be a key component in this.
Quote from RJ Kirk:“I’ve been a biotech investor for 27 years, and Intrexon is by far the best thing I’ve ever seen,” says Kirk, 56, who raises falcons and composes electronic music on a 7,200-acre cattle farm in rural Pulaski County, Va. He likens Intrexon to “the Google of the life sciences” and predicts that in a decade it could become “the largest, most significant company” in its burgeoning field.
because XON will be to life sciences what "Intel" is to the computer.I am also betting in a company where the CEO has personally invested 250M of his own cash. Name another pre-revenue company where the operating CEO has ever done the same? RJ Kirk has been successful in biotech for almost 3 decades, and he "just might know something, us common fools do not."
Sun, the India drug company holds or seems to control XON who is really an R&D company that still in the early stage of being profitable.
XON is in collaberation with AmpliPhi Biosciences Corp ( APHB - OTC ). Both have major articles in the Bio Mags (both past and present)and they could'nt be praised more. XON is a recent market entry and APHB is a penny stock with unheard of potential.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions